





















In today's rapidly evolving healthcare landscape, partnerships with pharma can provide startups with the resources and expertise needed to bring innovative therapies to market, while offering pharma companies access to cutting-edge research and potential blockbuster drugs. However, the decision to partner, and the timing of such partnerships, can be critical in determining a company's trajectory and long-term success.
This meeting will explore the intricacies of pharma partnerships, examining both the opportunities and challenges they present.
Join us to discuss:
How can startups structure partnerships to maintain control over key assets while still attracting pharma investment?
What regulatory changes could reshape the landscape for biotech-pharma collaborations in the coming years?
As the lines between tech and healthcare blur, how might non-traditional players impact the future of pharma partnerships?